Unlocking the Secret of Pain Management with Juva Life (OTCQB: JUVAF)
Publisher |
Josh Kincaid
Media Type |
audio
Categories Via RSS |
Business
Business News
Investing
News
Publication Date |
Jun 03, 2022
Episode Duration |
00:26:35

"What we identified is that the cannabinoids for inflammation controlling the primary cytokine pathways in the human body - cannabinoids have almost no therapeutic effects compared to JUVA  19 or JUVA 41." 

"When we combined any other cannabinoid - THC, CBD - the combination of flavonoids and what we would know as the entourage effect with any of our JUVA 41 or JUVA 19, it down-regulated their potency and activity, full stop!"  ~Doug Chloupek, the CEO and Founder of Juva Life

Doug Chloupek, the CEO and Founder of Juva Life (OTCQB: JUVAF) - Juva Life is a cannabis cultivation and life sciences company aimed of unlocking the secret of pain management, and has navigated the complex financial regulatory system in order to make Juva a publicly traded company in the USA, Canada, and Germany, collectively raising $38 Million to-date.

Episode 965 The #TalkingHedge interviews Doug Chloupek, CEO & Founder at Juva Life...

https://youtu.be/gy8MPyPXV0Q

 

 

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review